Your browser doesn't support javascript.
loading
Development of preclinical and clinical models for immune-related adverse events following checkpoint immunotherapy: a perspective from SITC and AACR.
Bayless, Nicholas L; Bluestone, Jeffrey A; Bucktrout, Samantha; Butterfield, Lisa H; Jaffee, Elizabeth M; Koch, Christian A; Roep, Bart O; Sharpe, Arlene H; Murphy, William J; Villani, Alexandra-Chloé; Walunas, Theresa L.
Afiliação
  • Bayless NL; Parker Institute for Cancer Immunotherapy, San Francisco, California, USA.
  • Bluestone JA; Diabetes Center, University of California San Francisco, San Francisco, California, USA.
  • Bucktrout S; Parker Institute for Cancer Immunotherapy, San Francisco, California, USA.
  • Butterfield LH; Parker Institute for Cancer Immunotherapy, San Francisco, California, USA.
  • Jaffee EM; Microbiology and Immunology, University of California San Francisco, San Francisco, California, USA.
  • Koch CA; Johns Hopkins Medicine Sidney Kimmel Comprehensive Cancer Center, Baltimore, Maryland, USA.
  • Roep BO; Fox Chase Cancer Center, Philadelphia, Pennsylvania, USA.
  • Sharpe AH; Department of Diabetes Immunology, Diabetes & Metabolism Research Institute at the Beckman Research Institute, City of Hope National Medical Center, Duarte, California, USA.
  • Murphy WJ; Department of Immunology, Blavatnik Institute, Harvard Medical School and Evergrande Center for Immunologic Diseases, Harvard Medical School, Boston, Massachusetts, USA.
  • Villani AC; Department of Dermatology, Institute for Regenerative Cures, University of California Davis, Sacramento, California, USA t-walunas@northwestern.edu wmjmurphy@ucdavis.edu avillani@mgh.harvard.edu.
  • Walunas TL; Center for Cancer Research, Center for Immunology and Inflammatory Diseases, Department of Medicine, Harvard Medical School, Massachusetts General Hospital, Boston, Massachusetts, USA t-walunas@northwestern.edu wmjmurphy@ucdavis.edu avillani@mgh.harvard.edu.
J Immunother Cancer ; 9(9)2021 09.
Article em En | MEDLINE | ID: mdl-34479924
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Contexto em Saúde: 1_ASSA2030 Problema de saúde: 1_sistemas_informacao_saude Assunto principal: Efeitos Colaterais e Reações Adversas Relacionados a Medicamentos / Imunoterapia Tipo de estudo: Guideline / Prognostic_studies / Risk_factors_studies Limite: Animals / Humans Idioma: En Revista: J Immunother Cancer Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Contexto em Saúde: 1_ASSA2030 Problema de saúde: 1_sistemas_informacao_saude Assunto principal: Efeitos Colaterais e Reações Adversas Relacionados a Medicamentos / Imunoterapia Tipo de estudo: Guideline / Prognostic_studies / Risk_factors_studies Limite: Animals / Humans Idioma: En Revista: J Immunother Cancer Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos